Results 41 to 50 of about 3,238 (182)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer

Frontiers in Oncology, 2019
Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone.
Caryn Wujanto, Balamurugan Vellayappan, Shankar Siva, Alexander V. Louie, Matthias Guckenberger, Ben J. Slotman, Hiroshi Onishi, Yasushi Nagata, Mitchell Liu, Simon S. Lo   +9 more
doaj   +1 more source

Magnetic resonance-guided stereotactic body radiation therapy for pancreatic oligometastases from renal cell carcinoma

Physics and Imaging in Radiation Oncology
Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median
Jonna K. van Vulpen, Hidde Eijkelenkamp, Guus Grimbergen, Frank J. Wessels, Sasja F. Mulder, Gert J. Meijer, Martijn P.W. Intven   +6 more
doaj   +1 more source

Clinical studies of chemotherapy efficacy in combination with androgenic deprivation in patients with oligometastatic hormone-sensitive prostate cancer

Медицинский совет, 2019
Prostate cancer is one of the most common malignant neoplasms in men. Nowadays, the overall mortality rate of this disease continues to increase, including due to the high frequency of primary detection of its widespread and metastatic forms.
S. V. Popov
doaj   +1 more source

The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis

Frontiers in Immunology, 2022
IntroductionThe efficacy of immunotherapy for treatment of patients with oligometastatic non-small cell lung cancer (NSCLC) at different metastatic sites remains controversial. We investigated the effect of different metastatic sites on immunotherapy for
Jia-Chun Ma, Jia-Chun Ma, Jing-Xin Zhang, Fei Wang, Jinming Yu, Jinming Yu, Jinming Yu, Dawei Chen   +7 more
doaj   +1 more source

New Strategies in Stereotactic Radiotherapy for Oligometastases [PDF]

Clinical Cancer Research, 2015
Abstract Patients with metastatic solid tumors are usually treated with palliative intent. Systemic therapy and palliative radiation are often used, with the goals of prolonging survival or maintaining quality of life, but not of cure.
David A, Palma, Alexander V, Louie, George B, Rodrigues   +2 more
openaire   +2 more sources

Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume

Journal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background In lung cancer radiotherapy, the volume of the lung receiving a dose above 20 Gy (V20Gy) and the mean lung dose are widely recognized dosimetric indicators for predicting radiation pneumonitis. However, there is currently no unified model to predict the minimum achievable values of V20Gy and mean lung dose.
Yu Wang, Deying Xu, Yunfeng Liu, Xiaofeng Zhang, Liang Yu   +4 more
wiley   +1 more source

Ablative radiotherapy in castration‐resistant prostate cancer

BJU International, Volume 138, Issue 4, Page 659-665, October 2026.
Objective To prove the oncological benefit of ablative radiotherapy in patients with up to five metastases from castration‐resistant prostate cancer (CRPC) a single‐centre randomised trial was initiated. Patients and Methods This monocentric, randomised, phase II clinical trial enrolled patients with up to five prostate‐specific membrane antigen ...
Tobias Hölscher, Fabian Lohaus, Lydia Koi, Jörg Kotzerke, Sebastian Hoberück, Christian Thomas, Angelika Borkowetz, Steffen Löck, Mechthild Krause, Esther G.C. Troost   +9 more
wiley   +1 more source

Improvement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach

Южно-Российский онкологический журнал
Purpose of the study. To improve the treatment results of patients suffering from CRC with oligometastatic lesion by determining the most effective combination of treatment methods.Patients and methods.
E. O. Kalmykova, R. V. Ishchenko, O. Yu. Stukalova, D. A. Filimonov   +3 more
doaj   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1368-1381, September 2026.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya, Koichi Yagi, Yoshifumi Baba   +2 more
wiley   +1 more source

Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study

International Journal of Hyperthermia, 2019
Purpose: Patients with oligometastatic non-small-cell lung cancer (NSCLC) benefit from local control treatments such as surgery or irradiation. The efficacy and safety of microwave ablation (MWA) in these patients was unknown.
Zhigang Wei, Xin Ye, Xia Yang, Guanghui Huang, Wenhong Li, Xiaoying Han, Jiao Wang, Min Meng, Yang Ni, Qingyu Li   +9 more
doaj   +1 more source